NCT05351307

Brief Summary

the study aims to detect ischemic changes in macula using OCT angiography in primary open angle glaucoma patients correlating with glaucoma staging system II by visual field.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 24, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 28, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

April 28, 2022

Status Verified

April 1, 2022

Enrollment Period

10 months

First QC Date

April 24, 2022

Last Update Submit

April 27, 2022

Conditions

Primary Open Angle Glaucoma

Outcome Measures

Primary Outcomes (1)

  • ischemic changes in macula

    Using OCT angiography to detect ischemic changes in macula

    Through one year

Study Arms (2)

POAG patients

OCT angiography will be performed

Normal participants

OCT angiography will be performed

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

\> 18 years primary open angle glaucoma patients

You may qualify if:

  • (\> 18 years old)

You may not qualify if:

  • patients with cataract
  • retinal disorders including: AMD , Macular degeneration , retinal detachment , retinitis pigmentosa , etc .
  • corneal opacites
  • any ocular surgeries
  • patients with systemic disease.
  • patient refusal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag University hospitals

Sohag, Egypt

Location

MeSH Terms

Conditions

Glaucoma, Open-Angle

Condition Hierarchy (Ancestors)

GlaucomaOcular HypertensionEye Diseases

Study Officials

  • Mohamed Iqbal Hafez, Assist prof

    Supervisor

    STUDY DIRECTOR

  • Hany Mahmoud Abdel Hamid, Lecturer

    Supervisor

    STUDY DIRECTOR

Central Study Contacts

Marwa Hamza, Resident

CONTACT

01018421051Marwahamza12@yahoo.com

Ismail Moussa Abd-Elatif, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

April 24, 2022

First Posted

April 28, 2022

Study Start

June 1, 2022

Primary Completion

April 1, 2023

Study Completion

June 1, 2023

Last Updated

April 28, 2022

Record last verified: 2022-04

Locations

EG(1)